Surveillance for Disease Progression of Transthyretin Amyloidosis after Heart Transplantation in the Era of Novel Disease Modifying Therapies

Heart Transplantation (HT) is a rational therapy for advanced transthyretin cardiac amyloidosis (ATTR-CA), but the impact of ongoing amyloid deposition is not well defined. We evaluated a cohort of patients who underwent HT for ATTR-CA to determine the incidence of de novo or progression of post-HT ATTR deposition.

Source: The Journal of Heart and Lung Transplantation - October 25, 2021 Category: Transplant Surgery Authors: Jan M Griffin, Eleonore Baughan, Hannah Rosenblum, Kevin J Clerkin, Justin A Fried, Jayant Raikhelkar, Nir Uriel, Thomas H Brannagan, Koji Takeda, Justin L. Grodin, Charles Marboe, Mathew S Maurer, Maryjane A Farr Tags: ISHT Meeting Source Type: research